Dual-Drug Strategy Achieves 83% Remission in Resistant Leukemia Cases
Adults facing acute myeloid leukemia with FLT3-ITD mutations—roughly 30% of all AML cases—have historically confronted dismal outcomes when standard…
Found 1715 results for "cancer"
Adults facing acute myeloid leukemia with FLT3-ITD mutations—roughly 30% of all AML cases—have historically confronted dismal outcomes when standard…
The paradox of cancer evolution just became clearer: while tumors appear genetically chaotic, they actually settle into remarkably stable chromosomal…
The limited success of immunotherapy in colorectal cancer patients may soon change as precision-engineered nanoparticles demonstrate new ways to overcome one…
Pancreatic cancer remains one of medicine's most formidable challenges, with five-year survival rates below 12% and limited treatment options after initial…
Diagnostic accuracy in cancer and tumor evaluation hinges on obtaining adequate tissue samples, yet conventional biopsy methods frequently fall short…
Understanding how cancer cells escape immune detection while spreading to distant organs could fundamentally change treatment strategies for aggressive…
Cellular aging mechanisms may work in reverse for some cancer patients, creating unexpected vulnerabilities where longevity pathways become disease drivers…
Heart attack recovery could be transformed by precision-guided immune therapy that directs healing cells exactly where cardiac tissue needs them most…
Asian lung cancer patients now have compelling evidence for choosing combination immunotherapy over single-drug treatment, with new data showing a 25%…
The immune system's ability to distinguish friend from foe may depend on previously overlooked mechanical forces that T cells exert during antigen…
Treatment-resistant prostate cancer may have met its match through an unexpected cellular vulnerability involving copper toxicity. When conventional…
The mystery of how certain crucial proteins enter cell nuclei without traditional molecular passports has been partially solved, revealing a previously…
Pancreatic cancer's notorious resistance to treatment may finally be yielding to a new generation of precisely targeted therapies. This development represents…
Pancreatic adenocarcinoma remains one of medicine's most formidable opponents, with five-year survival rates below 5% and limited treatment options once…
Natural experiment data from 60,768 UK Biobank participants revealed that sugar restriction during early life produces dose-dependent reductions in disease…
The development of chemotherapy resistance represents one of oncology's most pressing challenges, particularly for small cell lung cancer patients who face…
Nearly half of breast implant complications may stem from an overlooked culprit that standard surgical protocols fail to adequately address. This finding…
Pancreatic cancer remains one of medicine's most formidable challenges, with five-year survival rates below 12% despite decades of research. The discovery…
The emerging connection between metabolism and cancer risk gains molecular clarity through evidence that pancreatic cancer-associated genes are actively…
Brain cancer remains notoriously difficult to treat, largely because therapeutic agents struggle to cross the blood-brain barrier and tumor hypoxia renders…